IntelGenx to settle interest on 8% debentures due 2020 in stock

By Marisa Wong

Los Angeles, Dec. 6 – IntelGenx Technologies Corp. said it intends to issue common shares in payment of interest on its 8% convertible subordinated debentures due June 30, 2020.

The company plans to issue 415,178 common shares at a price of C$0.73 per share in payment of the C$303,080 of interest due on the debentures.

IntelGenx is a Saint Laurent, Quebec-based drug delivery company focused on the development and manufacturing of pharmaceutical films.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.